Aytu Biopharma, Inc financial data

Symbol
AYTU on Nasdaq
Industry
Pharmaceutical Preparations
Location
7900 E. Union Avenue, Suite 920, Denver, CO
State of incorporation
DE
Fiscal year end
June 30
Former names
AYTU BIOSCIENCE, INC (to 3/22/2021), Rosewind CORP (to 6/8/2015)
Latest financial report
10-Q - Q4 2024 - Feb 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 101 % +3.7%
Quick Ratio 17.8 % -2.26%
Debt-to-equity 253 % +55.6%
Return On Equity -61.9 % +51.5%
Return On Assets -4.38 % +66.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.17M shares +10.8%
Common Stock, Shares, Outstanding 6.17M shares +10.8%
Entity Public Float 10.7M USD -12.9%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.13M shares +11.1%
Weighted Average Number of Shares Outstanding, Diluted 8.49M shares +53.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 77.2M USD -14.2%
Cost of Revenue 41.2M USD -6.27%
Research and Development Expense 2.62M USD +7.63%
Selling and Marketing Expense 26.6M USD -17.2%
General and Administrative Expense 21M USD -13.9%
Operating Income (Loss) -10.2M USD -66.3%
Nonoperating Income (Expense) -7.71M USD -424%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.12M USD +61.1%
Income Tax Expense (Benefit) 1.11M USD -136%
Net Income (Loss) Attributable to Parent -5.24M USD +70.9%
Earnings Per Share, Basic -0.97 USD/shares +76.9%
Earnings Per Share, Diluted -0.26 USD/shares -550%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.4M USD +4.45%
Accounts Receivable, after Allowance for Credit Loss, Current 25.4M USD -13.6%
Inventory, Net 11.1M USD -14.7%
Other Assets, Current 63.1M USD +4630%
Assets, Current 71.1M USD -9.35%
Property, Plant and Equipment, Net 516K USD -54.2%
Operating Lease, Right-of-Use Asset 1.18M USD -44.8%
Intangible Assets, Net (Excluding Goodwill) 50M USD -10.3%
Goodwill 0 USD
Other Assets, Noncurrent 1.52M USD +67.8%
Assets 116M USD -11.4%
Accounts Payable, Current 11.7M USD +11.7%
Employee-related Liabilities, Current 3.97M USD +18.1%
Accrued Liabilities, Current 39.4M USD -9.31%
Liabilities, Current 64M USD -0.22%
Long-term Debt and Lease Obligation 9.98M USD -33.3%
Operating Lease, Liability, Noncurrent 1.11M USD
Other Liabilities, Noncurrent 5.05M USD -20.5%
Liabilities 101M USD -0.92%
Retained Earnings (Accumulated Deficit) -318M USD -1.68%
Stockholders' Equity Attributable to Parent 30.8M USD -6.36%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 32.2M USD -33.5%
Liabilities and Equity 116M USD -11.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -211K USD +97.7%
Net Cash Provided by (Used in) Financing Activities -2.73M USD -120%
Net Cash Provided by (Used in) Investing Activities -76K USD -281%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 6.17M shares +10.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.02M USD -168%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.8M USD +3.24%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.36M USD +141%
Deferred Tax Assets, Valuation Allowance 137M USD +0.95%
Deferred Tax Assets, Gross 138M USD +0.5%
Operating Lease, Liability 1.29M USD -41.8%
Depreciation 100K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid 2.2M USD -16.1%
Property, Plant and Equipment, Gross 1.17M USD -72.2%
Operating Lease, Liability, Current 182K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 377K USD +33.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 399K USD -57.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +33.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 479K USD +44.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 386K USD +60.2%
Deferred Tax Assets, Operating Loss Carryforwards 119M USD +4.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 1.31M USD -55.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 358K USD +79.9%
Operating Lease, Payments 168K USD -53.3%
Additional Paid in Capital 348M USD +0.91%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.21M USD +23.1%
Depreciation, Depletion and Amortization 2.23M USD -3.09%
Deferred Tax Assets, Net of Valuation Allowance 762K USD -44.7%
Share-based Payment Arrangement, Expense 1.49M USD -58.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%